Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.12555 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.15993 | 68 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.08502 | 67 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.03602 | 66 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.00538 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.17889 | 68 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.1287 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.07613 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.02756 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.02016 | 66 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.06698 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.15207 | 68 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.09737 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.05642 | 67 |